Glycopeptide Antibiotics Market to Reach $4.31 Billion by 2032, Driven by Rising MRSA Infections, Hospital-Acquired Infections. The Glycopeptide Antibiotics Market is entering a phase of measured yet critical growth, propelled by the relentless global rise in antimicrobial resistance (AMR), particularly methicillin-resistant Staphylococcus aureus (MRSA) and other multidrug-resistant Gram-positive pathogens. According to the latest comprehensive analysis […]








